Showing 881 - 900 results of 55,387 for search '(( 5 ((ng decrease) OR (we decrease)) ) OR ( 100 ((nn decrease) OR (a decrease)) ))', query time: 0.97s Refine Results
  1. 881
  2. 882
  3. 883

    Uptake and Population-Level Impact of Expedited Partner Therapy (EPT) on <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoeae</i>: The Washington State Community-Level Randomi... by Matthew R. Golden (136790)

    Published 2015
    “…We conducted a stepped-wedge, community-level randomized trial to determine whether a public health intervention promoting EPT could increase its use and decrease chlamydia test positivity and gonorrhea incidence in women.…”
  4. 884
  5. 885

    SDF1-mediated CXCR4-internalization in NG108-15 cells. by Katrin Feldbauer (3234774)

    Published 2016
    “…The specific cell capacitance (slope of the linear fit) decreases in presence of SDF1α. <b>b.</b> Confocal laser scanning micrographs of NG108-15 cells expressing CXCR4::eYFP in the presence of the inhibitor AMD3100 or the agonist SDF1α as indicated. …”
  6. 886
  7. 887
  8. 888

    S1 File - by Hiroomi Tatsumi (4818924)

    Published 2023
    “…The daily rate of PC transfusion decreased from 30.2% on days 1–5 to 18.2% on days 11–15. …”
  9. 889

    Dexamethasone decreases PGC-1α protein expression and transcription. by Jill A. Rahnert (2872766)

    Published 2016
    “…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”
  10. 890
  11. 891

    Dexamethasone decreases CRTC1 and CRTC2 nuclear localization. by Jill A. Rahnert (2872766)

    Published 2016
    “…<p>Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased (A) total CRTC1 (p = 0.004 and CRTC2 protein (p = 0.0007). n = 9/treatment from 3 experiments. …”
  12. 892
  13. 893
  14. 894
  15. 895

    Levosimendan protects human hepatocytes from ischemia-reperfusion injury by Stefanie N. Brunner (4598818)

    Published 2017
    “…After the hypoxic phase, reoxygenation was implemented and cells were treated with different concentrations of levosimendan (10ng/ml, 100ng/ml, 1000ng/ml). The overall metabolic activity of the cells was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and aspartate aminotransferase (AST) levels were determined in order to quantify hepatic injury. …”
  16. 896
  17. 897
  18. 898
  19. 899
  20. 900